SCA
CLVS

SAC Capital Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

SAC Capital Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-458,238
Closed -$31.7M – 1150
2014
Q1 		$31.7M Sell
458,238
-708,462
-61% -$52M 0.16% 170
2013
Q4 		$70.3M Buy
1,166,700
+79,325
+7% +$4.31M 0.41% 58
2013
Q3 		$66.1M Buy
1,087,375
+393,646
+57% +$27.9M 0.36% 67
2013
Q2 		$46.5M Buy
+693,729
New +$31.2M 0.26% 112

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

SAC Capital Advisors's CLVS Position: Q2 2014 in Review

SAC Capital Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2014, closing a stake of 458,238 shares — an estimated $31.7M sold.

SAC Capital Advisors first reported a position in CLVS in Q2 2013 and held it in 4 quarters. The position peaked at $70.3M in Q4 2013. 140 funds tracked by Wall St. Rank hold CLVS as of Q2 2014.

  • SAC Capital Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 458,238 Clovis Oncology, Inc. shares in Q2 2014, an estimated $31.7M.
  • SAC Capital Advisors first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Clovis Oncology, Inc. position peaked at $70.3M in Q4 2013.
  • 140 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.